Long-Term Biocompatibility of a Highly Viscously Thiol-Modified Cross-Linked Hyaluronate as a Novel Vitreous Body Substitute.

Hurst J, Rickmann A, Heider N, Hohenadl C, Reither C, Schatz A, Schnichels S, Januschowski K, Spitzer MS

Open source

DOI
10.3389/fphar.2022.817353
Published
2022
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2022.817353,
  title = {Long-Term Biocompatibility of a Highly Viscously Thiol-Modified Cross-Linked Hyaluronate as a Novel Vitreous Body Substitute.},
  author = {Hurst J and Rickmann A and Heider N and Hohenadl C and Reither C and Schatz A and Schnichels S and Januschowski K and Spitzer MS},
  year = {2022},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2022.817353},
  url = {https://doi.org/10.3389/fphar.2022.817353}
}

RIS

TY  - JOUR
TI  - Long-Term Biocompatibility of a Highly Viscously Thiol-Modified Cross-Linked Hyaluronate as a Novel Vitreous Body Substitute.
AU  - Hurst J
AU  - Rickmann A
AU  - Heider N
AU  - Hohenadl C
AU  - Reither C
AU  - Schatz A
AU  - Schnichels S
AU  - Januschowski K
AU  - Spitzer MS
PY  - 2022
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2022.817353
UR  - https://doi.org/10.3389/fphar.2022.817353
ER  - 

APA

J, H., A, R., N, H., C, H., C, R., A, S., S, S., K, J., & MS, S. (2022). Long-Term Biocompatibility of a Highly Viscously Thiol-Modified Cross-Linked Hyaluronate as a Novel Vitreous Body Substitute.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2022.817353

Source records